1de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[ J ]. Lancet Oncol, 2010,11 ( 11 ) : 1048-1056.
2Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer [J]. N Engl J Med, 2003,348(6) :518-527.
3Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer[J]. Lancet, 2007,370(9590):890-907.
6Bosch FX, de Sanjose S. The epidemiology of human papillomavirus infection and cervical cancer[J].Dis Markers, 2007,23 (4) :213- 227.
7Grce M, Husnjak K, Matovina M, et al. Human papillomavirus, cytomegalovirus, and adeno-associated virus infections in pregnant and nonpregnant women with cervical intraepithelial neoplasia[ J]. J Clin Microbiol, 2004,42 ( 3 ) : 1341-1344.
8Holmes RS, Hawes SE, Toure P, et al. HIV infection as a risk factor for cervical cancer and cervical intraepithelial neoplasia in Senegal[ J]. Cancer Epidemiol Biomarkem Prey, 2009, 18 ( 9 ) : 2442- 2446.
9Simonetti AC, Melo JH, de Souza PR, et al. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor[J]. Microbes Infect, 2009,11 (4) :435-442.
10Safaeian M, Quint K, Schiffman M, et al. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort [ J ]. J Natl Cancer Inst, 2010, 102 ( 23 ) : 1794 - 1804.
二级参考文献32
1Schottenfeld D, Bcebehe-diminer JL. Advances in cancer epidemlology: understanding causal mechanisms and the evidence for implementing interventions [J]. Annu Rev Public Health, 2005, 26:37-60.
2Bulk S, Berkhof J, Bulkmans NW, et al. Preferential risk of HPV16 for squamous cell carcinoma and of HPV 18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands[J]. Br J Cancer, 2006, 94(1): 171-175.
3Chen W, Zhang X, Molijn A, et al. Human papillomavirus type-distribution in cervical cancer in China: the impor- tance of HPV 16 and 18[J]. Cancer Causes Control, 2009, 20(9):1705-1713.
4Altekruse SF, Lacey JV, Brinton LA,et al. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adcnocarcinoma and squamous cell carcinoma: Northeastern United States [J]. Am J Obstet Gynecol, 2007, 188(3):657-663.
6Song SH, Lee JK, Oh M J, et al. Risk factors for the pro- gression or persistence of untreated mild dysplasia of the uterine cervix[J]. Int J Gynecol Cancer, 2006, 16(4):1608- 1613.
7Nunez-Troeonis J, Delgado M, Gonzalez J, et al. Preva- lence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area[J]. Invest Clin, 2009, 50(2):203-212.
8Wu QJ, Guo M, Lu ZM, et al. Detection of human papillo-mavims-16 in ovarian malignancy [J]. Br J Cancer,2003, 89(4):672-675.
9Atalay F, Taskiran C, Taner MZ, et al. Detection of human papillomavirus DNA and genotyping in patients with epithe- lial ovarian carcinmna [J]. J Obstet Gynaecol Res, 2007, 33(6): 823-828.
10Sutton BC, Allen RA, Moore WE, et al. Distribution of hu- man papillomavirus genotypes in invasive squamous carci- noma of the vulva[J]. Mod Pathol, 2008, 21(3):345-354.
3Pallesen G,Hamilton-Dutoit SJ,Zhou XG.The association of Epstein-Barr Virus(EBV)with T cell lymphoproliferations and Hodgkin‘s disease two new developments in the EBV field[].Advances in Cancer Research.1993
4Jemal A,Siegel R,Xu J,et a1.Cancer statistics 2010[].CA A Cancer Journal for Clinicians.2011
